KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Gross Profit (2020 - 2025)

Ginkgo Bioworks Holdings' Gross Profit history spans 6 years, with the latest figure at $18.6 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 61.08% year-over-year to $18.6 million; the TTM value through Dec 2025 reached $137.7 million, down 34.17%, while the annual FY2025 figure was $141.3 million, 37.78% down from the prior year.
  • Gross Profit reached $18.6 million in Q4 2025 per DNA's latest filing, down from $30.7 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $79.1 million in Q3 2024 to a low of -$116.4 million in Q1 2023.
  • Average Gross Profit over 5 years is $4.7 million, with a median of $27.1 million recorded in 2022.
  • The largest YoY upside for Gross Profit was 6219.09% in 2023 against a maximum downside of 488.38% in 2023.
  • A 5-year view of Gross Profit shows it stood at -$32.3 million in 2021, then surged by 101.7% to $550000.0 in 2022, then soared by 6219.09% to $34.8 million in 2023, then skyrocketed by 37.47% to $47.8 million in 2024, then tumbled by 61.08% to $18.6 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Gross Profit are $18.6 million (Q4 2025), $30.7 million (Q3 2025), and $44.2 million (Q2 2025).